Objective Programmed death-1(PD-1)blocking antibodies have been shown to improve progression-free survival(PFS)and overall survival in a subset of patients with non–small cell lung cancer(NSCLC).
Objective Objective: Breast cancer and obesity remains a major global womens health problem.Adipose tissue plays a role in the association between obesity and breast cancer.